Augenzentrum Am St Franziskus-Hospital Muenster

At Augenzentrum Am St Franziskus-Hospital Muenster, the clinical trial portfolio is centered on ophthalmology and a broad range of eye diseases. The studies focus on conditions that affect central vision and retinal health, with research aimed at testing new treatments, comparing treatment options, and improving long-term disease control.

• Diabetic macular edema and centre-involved diabetic macular edema
• Age-related macular degeneration, including dry and neovascular forms
• Geographic atrophy and related retinal degeneration

This work reflects a strong interest in preserving vision in common retinal disorders, especially through therapies designed to slow progression, reduce retinal swelling, and maintain visual function over time.

The site is actively studying retinal diseases that damage the macula and lead to vision loss, including diabetic macular edema, macular edema secondary to retinal vein occlusion, and neovascular age-related macular degeneration. These trials are mainly evaluating whether newer eye treatments can match or improve established care while supporting better visual outcomes.

• Testing new options for macular swelling and retinal vein-related vision loss
• Comparing novel therapies with standard anti-VEGF treatment
• Assessing whether longer-lasting treatment approaches can maintain vision

The research program at Augenzentrum Am St Franziskus-Hospital Muenster highlights practical questions about how to keep treatment effective while reducing the burden of repeated eye care visits.

A major part of the research focuses on dry age-related macular degeneration and geographic atrophy, two progressive conditions that can gradually erode central vision. Studies in this area are exploring new therapies that may slow lesion growth, protect retinal tissue, and support long-term visual preservation.

• Geographic atrophy linked to age-related macular degeneration
• Dry AMD with geographic atrophy
• Therapies intended to slow progression and reduce vision decline

This therapeutic area includes research on treatment safety, durability, and effectiveness, showing a clear emphasis on managing chronic retinal degeneration before severe vision loss develops.

The clinical trials also cover non-infectious uveitis, including intermediate uveitis, posterior uveitis, and panuveitis. These studies are evaluating new ways to control ocular inflammation, reduce relapse risk, and improve symptom management in both adults and children.

• Inflammatory eye disease affecting the posterior segment
• Pediatric and adult non-infectious uveitis
• Research aimed at improving disease control and treatment tolerability

The work in this area supports better care for patients with chronic inflammatory eye disease, where long-term control is important for protecting sight and quality of life.